Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in adults with fibrous dysplasia of bone
ChiCTR2400080753Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Feb 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of denosumab in fibrous dysplasia, sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Bone turnover markers. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
denosumab
03
Conditions
fibrous dysplasia
Beyond the preview
Go deeper on ChiCTR2400080753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080753.